In Precision Medicine & Companion Diagnostics
Precision Medicine can provide several services to support your rare and orphan diseases drug development programs. We can support your programs with biomarker discovery services, target validation, and sequencing services for patient stratification amongst others. Our fast turnaround time for our services ensures that you have the most reliable and accurate information in the shortest time possible. We can support the different stages of your development program with tailored solutions most appropriate for your needs balancing cost vs. other benefits.
In Central Lab Services
At Medicover Integrated Clinical Services, our commitment to advancing healthcare extends to the forefront of rare disease and orphan drug development through our specialized Central Lab Services. Recognizing the distinct challenges posed by rare diseases, we have precisely crafted a tailored approach that combines cutting-edge diagnostics with comprehensive testing protocols. Our dedicated team of experts, equipped with advanced technologies, ensures precision and reliability in every analysis. By offering a robust foundation for orphan drug development, we not only contribute to breakthrough therapies but also uphold the highest standards of quality and efficiency, reinforcing our position as a trusted partner in pioneering advancements for patients with unique medical needs.